43 related articles for article (PubMed ID: 17269158)
1. Rational prioritization strategy allows the design of macrolide derivatives that overcome antibiotic resistance.
König G; Sokkar P; Pryk N; Heinrich S; Möller D; Cimicata G; Matzov D; Dietze P; Thiel W; Bashan A; Bandow JE; Zuegg J; Yonath A; Schulz F; Sanchez-Garcia E
Proc Natl Acad Sci U S A; 2021 Nov; 118(46):. PubMed ID: 34750269
[TBL] [Abstract][Full Text] [Related]
2. From Immunologically Archaic to Neoteric Glycovaccines.
Cavallari M; De Libero G
Vaccines (Basel); 2017 Jan; 5(1):. PubMed ID: 28134792
[TBL] [Abstract][Full Text] [Related]
3. Novel Synthesis of Kanamycin Conjugated Gold Nanoparticles with Potent Antibacterial Activity.
Payne JN; Waghwani HK; Connor MG; Hamilton W; Tockstein S; Moolani H; Chavda F; Badwaik V; Lawrenz MB; Dakshinamurthy R
Front Microbiol; 2016; 7():607. PubMed ID: 27330535
[TBL] [Abstract][Full Text] [Related]
4. Identifying producers of antibacterial compounds by screening for antibiotic resistance.
Thaker MN; Wang W; Spanogiannopoulos P; Waglechner N; King AM; Medina R; Wright GD
Nat Biotechnol; 2013 Oct; 31(10):922-7. PubMed ID: 24056948
[TBL] [Abstract][Full Text] [Related]
5. Fighting superbugs with superdrugs.
Carey J
Drug Discov Today; 2004 Aug; 9(15):637-40. PubMed ID: 15279846
[No Abstract] [Full Text] [Related]
6. The bacteria fight back.
Taubes G
Science; 2008 Jul; 321(5887):356-61. PubMed ID: 18635788
[No Abstract] [Full Text] [Related]
7. Antibiotics at the crossroads.
Nathan C
Nature; 2004 Oct; 431(7011):899-902. PubMed ID: 15496893
[No Abstract] [Full Text] [Related]
8. Antibiotics: a shot in the arm.
Leeb M
Nature; 2004 Oct; 431(7011):892-3. PubMed ID: 15496888
[No Abstract] [Full Text] [Related]
9. The antibacterial drugs market.
Kresse H; Belsey MJ; Rovini H
Nat Rev Drug Discov; 2007 Jan; 6(1):19-20. PubMed ID: 17269159
[No Abstract] [Full Text] [Related]
10. A call to arms.
Nat Rev Drug Discov; 2007 Jan; 6(1):8-12. PubMed ID: 17269158
[No Abstract] [Full Text] [Related]
11. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
Thomson CJ; Power E; Ruebsamen-Waigmann H; Labischinski H
Curr Opin Microbiol; 2004 Oct; 7(5):445-50. PubMed ID: 15451498
[TBL] [Abstract][Full Text] [Related]
12. The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance.
Bergström R
Drug Resist Updat; 2011 Apr; 14(2):77-8. PubMed ID: 21493123
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
